Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThruvision Grp Regulatory News (THRU)

Share Price Information for Thruvision Grp (THRU)

Share Price is delayed by 15 minutes
Get Live Data
0.725    0.00 (0.00%)
Bid:
0.70
Ask:
0.75
Spread: 0.05 (7.143%)
Market Cap: £3.24m
THRU Live PriceLast checked at - London Stock Exchange

Intraday Thruvision Grp Share Chart

Trading Update

3 Oct 2019 07:00

RNS Number : 5890O
Thruvision Group PLC
03 October 2019
 

3 October 2019

 

Thruvision Group plc

 

("Thruvision" or the "Group")

 

Trading Update

 

 

Thruvision (AIM: THRU) the specialist provider of people-screening technology to the international security market, is pleased to provide an update on trading for the six months ended 30 September 2019, the first half of the Group's financial year.

 

The Group has continued to drive good commercial momentum, with revenues increasing by 50% to £4.8 million (H1 FY19: £3.2 million). This was based on delivering 64 units to customers (H1 FY19: 60), of which a greater proportion in this period were high-end units helping to deliver stronger revenues and gross margins than in prior years. Cash at 30 September 2019 remained healthy at £8.7 million (31 March 2019: £9.4 million).

 

Sales momentum was particularly strong in our Customs market segment. Thruvision's combined strengths of safe and non-intrusive technology, along with an ability to reliably detect non-metallic items like drugs and bank notes, is helping to cement the Group's leading position in this international market. During the period Macau Customs and US Customs and Border Protection became our seventh and eighth customers respectively, while Hong Kong Customs and the US State Department's Bureau of International Narcotics & Law Enforcement Affairs both returned to purchase additional units in the period.

 

Good strategic progress continued to be made in our aviation segment with Thruvision being purchased by Los Angeles International Airport for employee screening purposes, and further technical progress made toward being approved for use in passenger screening in US airports by the TSA's Innovation Task Force.

 

In Loss Prevention, Morrisons became an important new customer in the grocery sector. Following this important win, the Group's new Loss Prevention sales team has significantly strengthened its sales pipeline in this area, with existing customers continuing to report a rapid return on investment when purchasing Thruvision units.

 

Growing international brand recognition, strategic progress across the US Federal Government, healthy R&D, and a strengthening sales pipeline re-affirms the Board's confidence in the prospects for the Group.

 

 

For further information please contact:

 

Thruvision Group plc +44 (0)1235 425400

Tom Black, Chairman

Colin Evans, Chief Executive

 

Investec Investment Banking (NOMAD & Broker) +44 (0)20 7597 5970

Sebastian Lawrence / Patrick Robb / James Rudd

 

FTI Consulting LLP +44 (0)20 3727 1000

Matt Dixon / Shamma Kelly

 

 

 

About Thruvision

Thruvision is the leading provider of next-generation people-screening technology. Using patented passive terahertz technology, Thruvision is uniquely capable of detecting metallic and non-metallic threats including weapons, explosives and contraband items that are hidden under clothing, at distances up to 10m.

 

Addressing the growing need for fast, safe and effective security, Thruvision has been vetted and approved by the US Transportation Security Administration for surface transportation. Operationally deployed in 20 countries around the world, Thruvision is used for a range of applications including mass transit and aviation security, facilities and public area protection, customs and border control and supply chain loss prevention. The company has offices near Oxford, in Washington DC, and in Sydney.

 

www.thruvision.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLLFETIILFIIA
Date   Source Headline
28th Feb 20258:38 amGNWForm 8.5 (EPT/RI) - Thruvision Group plc
26th Feb 20253:16 pmRNS-RNew product launch
18th Feb 202512:45 pmGNWForm 8.3 - [THRUVISION GROUP PLC- 17 02 2025] - (CGAML)
18th Feb 20258:00 amGNWForm 8.5 (EPT/RI)-Thruvision Group plc
17th Feb 202511:21 amGNWForm 8.3 - [THRUVISION GROUP PLC- 14 02 2025] - (CGAML)
17th Feb 202511:14 amRNSForm 8.3 - Thruvision Group plc
17th Feb 20258:27 amGNWForm 8.5 (EPT/RI)-Thruvision Group plc
14th Feb 202512:02 pmRNSForm 8.3 - Thruvision Group plc
14th Feb 20259:09 amGNWForm 8.5 (EPT/RI) - Thruvision Group plc
13th Feb 20257:00 amRNSTrading update and Progress on Strategic Review
7th Feb 20252:08 pmRNSForm 8.3 - Thruvision Group PLC
7th Feb 202512:14 pmRNSHolding(s) in Company
7th Feb 202510:52 amRNSForm 8.3 - Thruvision Group plc
7th Feb 20258:17 amGNWForm 8.5 (EPT/RI) - Thruvision Group plc
6th Feb 20255:05 pmRNSForm 8.3 - Thruvision Group PLC
6th Feb 202512:08 pmRNSForm 8.3 - Thruvision Group PLC
6th Feb 202510:43 amRNSRule 8.3 - Thruvision Group PLC
4th Feb 202512:06 pmRNSForm 8.3 - Thruvision Group PLC
30th Jan 202510:58 amGNWForm 8.5 (EPT/RI) - Thruvision Group plc
29th Jan 202511:38 amRNSForm 8.3 - Thruvision Group plc
24th Jan 20256:00 pmRNSForm 8.3 - Thruvision Group plc
23rd Jan 20251:53 pmRNSForm 8.3 - Thruvision Group PLC
22nd Jan 20255:03 pmRNSForm 8.3 - Thruvision Group PLC
21st Jan 20251:56 pmRNSForm 8.3 - Thruvision Group PLC
20th Jan 202512:12 pmRNSForm 8.3 - Thruvision Group PLC
20th Jan 20257:00 amRNSForm 8.3 - Thruvision Group plc
17th Jan 202512:11 pmRNSForm 8.3 - Thruvision Group plc
16th Jan 202511:29 amRNSForm 8.3 - Thruvision Group plc
15th Jan 20255:38 pmRNSForm 8 (OPD) - Thruvision Group plc
15th Jan 20251:12 pmGNWForm 8.3 - [THRUVISION GROUP PLC - Opening Disclosure - 14 01 2025] - (CGAML)
15th Jan 202512:58 pmGNWInvesco Ltd: Form 8.3 -Thruvision Group PLC; Opening position disclosure
15th Jan 202512:09 pmRNSForm 8.3 - Thruvision Group PLC
15th Jan 202511:42 amRNSForm 8.3 - Thruvision Group plc
15th Jan 202511:05 amRNSForm 8.3 - Thruvision Group Plc
15th Jan 20258:53 amGNWForm 8.5 (EPT/RI)-Thruvision Group plc
14th Jan 20257:00 amRNSStrategic Review
30th Dec 20247:00 amRNSAppointment of Chief Executive Officer
13th Dec 202412:38 pmRNSSharesave option grant to Executive Director
20th Nov 202410:45 amRNSBlocklisting update
20th Nov 202410:41 amRNSBlocklisting update
18th Nov 202410:50 amRNSAward of Share Options to Executive Director
15th Nov 20245:00 pmRNSHolding(s) in Company
14th Nov 202412:34 pmRNSHolding(s) in Company
12th Nov 20247:00 amRNSIssue of Equity
24th Oct 20247:00 amRNSInterim Results
14th Oct 20247:00 amRNSHalf year trading update and Board changes
19th Sep 202411:50 amRNSResult of AGM
28th Jun 20247:00 amRNSFinal Results
12th Jun 20247:00 amRNSResults notification
3rd Jun 20247:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.